Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes.

Saved in:
Bibliographic Details
Title: Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes.
Authors: Artzy-Schnirman A; Department of Materials, Department of Bioengineering and Institute for Biomedical Engineering, Imperial College London, Prince Consort Road, London SW7 2AZ, U.K., Abu-Shah E; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7FY, U.K.; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, U.K., Chandrawati R; Department of Materials, Department of Bioengineering and Institute for Biomedical Engineering, Imperial College London, Prince Consort Road, London SW7 2AZ, U.K., Altman E; Laboratory of Molecular Immunology, Faculty of Biology and Technion Integrated Cancer Center, Technion-Israel Institute of Technology, Haifa 3200003, Israel., Yusuf N; Department of Immunobiology, Guy's, King's & St Thomas' School of Medicine, second Floor, New Guy's House, Guy's Hospital, London SE1 9RT, U.K., Wang ST; Department of Materials, Department of Bioengineering and Institute for Biomedical Engineering, Imperial College London, Prince Consort Road, London SW7 2AZ, U.K., Ramos J; Department of Materials, Department of Bioengineering and Institute for Biomedical Engineering, Imperial College London, Prince Consort Road, London SW7 2AZ, U.K., Hansel CS; Department of Materials, Department of Bioengineering and Institute for Biomedical Engineering, Imperial College London, Prince Consort Road, London SW7 2AZ, U.K., Haus-Cohen M; Laboratory of Molecular Immunology, Faculty of Biology and Technion Integrated Cancer Center, Technion-Israel Institute of Technology, Haifa 3200003, Israel., Dahan R; Department of Systems Immunology, Weizmann Institute of Science, Rehovot 761001, Israel., Arif S; Department of Immunobiology, Guy's, King's & St Thomas' School of Medicine, second Floor, New Guy's House, Guy's Hospital, London SE1 9RT, U.K., Dustin ML; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7FY, U.K., Peakman M; Department of Immunobiology, Guy's, King's & St Thomas' School of Medicine, second Floor, New Guy's House, Guy's Hospital, London SE1 9RT, U.K., Reiter Y; Laboratory of Molecular Immunology, Faculty of Biology and Technion Integrated Cancer Center, Technion-Israel Institute of Technology, Haifa 3200003, Israel., Stevens MM; Department of Materials, Department of Bioengineering and Institute for Biomedical Engineering, Imperial College London, Prince Consort Road, London SW7 2AZ, U.K.
Source: Nano letters [Nano Lett] 2022 Jun 08; Vol. 22 (11), pp. 4376-4382. Date of Electronic Publication: 2022 May 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101088070 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-6992 (Electronic) Linking ISSN: 15306984 NLM ISO Abbreviation: Nano Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-6992
DOI:10.1021/acs.nanolett.2c00819